topnaman | Malaria blog

Two events prompted this post. First, several people have asked me if the malaria vaccine they heard about in the news will eliminate malaria. Second, the GSK CEO Andrew Witty discussed pricing strategies (5% profit above the yet unknown production costs) for this vaccine, called RTS,S, at a recent talk. Wait – pricing? We don’t [...]

I accidentally stumbled across the site Gooz News a year ago. Gooz News is the blog of longtime writer and reporter Merrill Goozner.  It was a fortuitous find of some rather interesting malaria thoughts (in both the actual posts as well as reader comments) that I have not seen elsewhere – particularly those which provided [...]

The latest issue of the New England Journal of Medicine contains a large set of malaria articles  including results from the RTS,S vaccine phase 2 trials. RTS,S is the malaria vaccine furthest along in the development pipeline and is managed by a public-private partnership led by GlaxoSmithKline and the PATH Malaria Vaccine Initiative (the early [...]

I should begin with a disclaimer – I’m not a malaria vaccine researcher. The idea I’m proposing may be a dead end, or possess some fatal flow unknown to me. Still, from what I do know, it seems to make a lot of sense. I came to this idea after looking into older research regarding [...]